مقارنة فعالية ديكلوفيناك الصوديوم مع ديكساميتازون فوسفات موضعيا ًكمضاد التهاب بعد عمليات الساد

Authors

  • قحطان جلول
  • يوسف سليمان
  • معتصم بركات

Abstract

شملت الدراسة 30 مريضاً خضعوا لجراحة استخراج ساد خارج المحفظة مع زرع عدسة بيت خلفي وذلك في مشفى الأسد الجامعي باللاذقية لدراسة تأثير ديكلوفيناك الصوديوم 0.1% كبديل للديكساميتازون فوسفات 0.1% موضعياً لعلاج الالتهاب بعد العمل الجراحي, تم تقسيم المرضى بالتساوي إلى مجموعتين . كان المرضى في كلا المجموعتين متساوين بالمقاييس الأساسية, وتم تقييم احتقان الملتحمة, وذمة القرنية, شدة ارتكاس البيت الأمامي, والضغط داخل العين ومقارنتها في الأيام 1,3,7,21,42.

لم تظهر الدراسة فارقاً إحصائياً في التأثير العلاجي في كلا المجموعتين (p<0.05) و لم تلاحظ مضاعفات مهمة في كلا المجموعتين, يعد الديكوفيناك الموضعي بفعالية الديكساميتازون نفسها ويمكن استخدامه بشكل آمن في العلاج الروتيني للالتهاب بعد عمليات الساد غير المختلطة .

The study included 30 patients who had undergone ECCE-PCIOL surgery at Al- Assad University Hospital to study the effect of topical diclofenac sodium 0.1% as alternative to topical dexamethason phosphate 0.1% for treatment of postoperative inflammation. The patients were equally divided. Both groups were similar in baseline parameters. Severity of anterior chamber reaction (AC-reaction), corneal oedema, conjunctival injection and IOP were evaluated and compared on days 1, 3, 7, 21 and 42. The two groups did not differ statistically in treatment effect for any of the variables (p<0.05). No significant complication was seen in the two groups. Topical diclofenac is as effective as topical dexamethason and can be used safely in routin postoperative treatment following uncomplicated surgery.

Downloads

Published

2019-01-17

How to Cite

1.
جلول ق, سليمان ي, بركات م. مقارنة فعالية ديكلوفيناك الصوديوم مع ديكساميتازون فوسفات موضعيا ًكمضاد التهاب بعد عمليات الساد. Tuj-hlth [Internet]. 2019Jan.17 [cited 2024Apr.27];30(3). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6550

Issue

Vol. 30 No. 3 (2008): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 3 4 > >>